Correlation Between Akero Therapeutics and Avidity Biosciences
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Avidity Biosciences, you can compare the effects of market volatilities on Akero Therapeutics and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Avidity Biosciences.
Diversification Opportunities for Akero Therapeutics and Avidity Biosciences
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Akero and Avidity is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Avidity Biosciences go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Avidity Biosciences
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.76 times more return on investment than Avidity Biosciences. However, Akero Therapeutics is 1.32 times less risky than Avidity Biosciences. It trades about 0.11 of its potential returns per unit of risk. Avidity Biosciences is currently generating about -0.02 per unit of risk. If you would invest 2,971 in Akero Therapeutics on August 29, 2024 and sell it today you would earn a total of 246.00 from holding Akero Therapeutics or generate 8.28% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Akero Therapeutics vs. Avidity Biosciences
Performance |
Timeline |
Akero Therapeutics |
Avidity Biosciences |
Akero Therapeutics and Avidity Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akero Therapeutics and Avidity Biosciences
The main advantage of trading using opposite Akero Therapeutics and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Avidity Biosciences vs. Bright Minds Biosciences | Avidity Biosciences vs. HP Inc | Avidity Biosciences vs. Intel | Avidity Biosciences vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |